In this video, José L. Güell, MD, moderator of the session on genetics at the virtual EuCornea congress, speaks about the new frontier of genetic therapy for corneal dystrophies.
Uncategorized
FDA Clears Masimo’s Go Anywhere Pulse Oximeter and Respiration Rate Monitor
Masimo won FDA clearance for its Rad-G pulse oximeter, a rugged device developed with the help of The Bill & Melinda Gates Foundation. Originally created to spot-check patients for SpO2 (oxygen saturation), respiration rate from the plethysmograph (RRp), pulse rate (PR), perfusion index (Pi), and pleth variability index (PVi®), this latest (Read more...)
Does Residual Fluid Matter in Wet AMD?
Dr Sophie Bakri surveys the data on how fluid presence and type affect visual outcomes after treat-and-extend anti-VEGF therapy. Medscape Ophthalmology
Eyewear Market to Reach USD 57.69 bn by 2024, Bausch Health Companies Inc and Carl Zeiss AG Emerge as Key Contributors to Growth | Technavio
LONDON–(BUSINESS WIRE)– #EyewearMarket–The Global Eyewear Market will grow by USD 57.69 bn during 2020-2024
Amerigroup Introduces Medicare Advantage Plan to Help Iowans Eligible for Medicare and Medicaid Lead Healthier Lives
DES MOINES, Iowa–(BUSINESS WIRE)–Amerigroup is introducing a 2021 Medicare Advantage plan for Iowans eligible for Medicare and Medicaid to help them improve their health and wellbeing. This plan will be available in 21 Iowa counties and will offer me…
Uncategorized
Phase 2 trial of OTX-CSI for dry eye underway
The first patients have been dosed in a phase 2 clinical trial of OTX-CSI for the treatment of dry eye disease, according to a press release from Ocular Therapeutix.The U.S.-based, randomized, masked, multicenter trial is investigating two formulations…